APA (7th ed.) Citation

Bergel, C. C., Eryilmaz, I. E., Cecener, G., & Egeli, U. Second-generation BRAF inhibitor Encorafenib resistance is regulated by NCOA4-mediated iron trafficking in the drug-resistant malignant melanoma cells. Nature Portfolio.

Chicago Style (17th ed.) Citation

Bergel, Ceyda Colakoglu, Isil Ezgi Eryilmaz, Gulsah Cecener, and Unal Egeli. Second-generation BRAF Inhibitor Encorafenib Resistance Is Regulated by NCOA4-mediated Iron Trafficking in the Drug-resistant Malignant Melanoma Cells. Nature Portfolio.

MLA (9th ed.) Citation

Bergel, Ceyda Colakoglu, et al. Second-generation BRAF Inhibitor Encorafenib Resistance Is Regulated by NCOA4-mediated Iron Trafficking in the Drug-resistant Malignant Melanoma Cells. Nature Portfolio.